NYSE: HIMS Archives

Hims & Hers (NYSE: HIMS) Shares Jump on Analyst Upgrades Despite Mixed Q1 Results

Hims & Hers Health (NYSE: HIMS) stock surged more than 18% in regular trading on Tuesday after several analysts raised […]

Salman Akhtar / 30 April 2025

Shares of Hims & Hers Health (NYSE: HIMS) surged over 23% in intraday trading on Tuesday, following the announcement of

Shares of Hims & Hers Health (NYSE: HIMS) fell 9% on Thursday after Chief Operating Officer Melissa Baird sold $910,687

Jennifer Tacker / 25 February 2025

Hims & Hers Health (NYSE: HIMS) stock plummeted more than 18% in after-hours trading on Monday after the telehealth company

Edward Cooke / 21 February 2025

Shares of Hims & Hers Health (NYSE: HIMS) plunged 23% on Friday after the U.S. Food and Drug Administration (FDA)

Kevin Putnam / 20 February 2025

Canaccord Genuity analyst Maria Ripps raised her price target for Hims & Hers Health (NYSE: HIMS) to $68.00, up from

Edward Cooke / 19 February 2025

Hims & Hers Health (NYSE: HIMS) stock surged about 20% on Wednesday following the announcement of its acquisition of Trybe

Zabih Ullah / 18 September 2024

NEW YORK – On Wednesday, Hims & Hers Health (NYSE: HIMS), the U.S. telehealth company, said it will sell compounded

Hims & Hers Health (NYSE: HIMS) stock soared 28% in intraday trading Monday after the telehealth company announced the addition